Skip to main content

Table 1 Characteristics of the 243 included patients with confirmed systemic lupus erythematosus a

From: Application of the 2012 Systemic Lupus International Collaborating Clinics classification criteria to patients in a regional Swedish systemic lupus erythematosus register

Characteristics

All confirmed SLE cases ( N= 243)

ACR-82 ( n= 197)

Fries only ( n= 46)

ACR-82 vs. Fries P -values

Mean

(Range)

Mean

(Range)

Mean

(Range)

 

Fulfilled ACR-82 criteria, n

4.6

(3 to 9)

5.0

(4 to 9)

3.0

(3 to 3)

<0.0001b

SLICC/ACR damage index

1.6

(0 to 9)

1.7

(0 to 9)

1.2

(0 to 7)

0.25b

Disease duration, yr

15.1

(0 to 52)

15.6

(0 to 52)

12.9

(1 to 40)

0.18b

Age, yr

52.8

(20 to 92)

52.2

(20 to 92)

55.6

(20 to 82)

0.20b

Female sex, %

87.7

87.5

89.1

0.74b

Caucasians, %

92.2

91.4

95.7

0.33b

Clinical manifestations (%)

    

Acute cutaneous lupus

65.8

71.6

41.3

<0.0001c

Chronic cutaneous lupus

15.2

17.8

4.3

0.023c

Photosensitivity

50.6

56.3

26.1

0.0002c

Nonscarring alopecia

21.4

22.3

17.4

0.46c

Oral ulcers

11.1

12.7

4.3

0.11c

Arthritis

75.7

76.1

73.9

0.75c

Pleuritis

37.9

39.1

32.6

0.41c

Pericarditis

14.8

15.2

13.0

0.71c

Renal disorder

23.9

28.9

2.2

<0.0001c

Biopsy-proven lupus nephritis

19.8

23.9

2.2

0.0009c

Neurologic disorder (ACR-82)

4.9

5.6

2.2

0.34c

Neurologic disorder (SLICC-12)

10.7

12.7

2.2

0.038c

Haemolytic anaemia

4.9

6.1

0

0.086c

Leukopenia

29.2

33.0

13.0

0.0074c

Lymphopenia

29.2

34.0

8.7

0.0007c

Thrombocytopenia

11.5

12.7

6.5

0.24c

Immunologic criteria (%)

    

Antinuclear antibody

98.8

98.5

100.0

0.40c

Anti-dsDNA

45.3

53.3

10.9

<0.0001c

Anti-Sm

8.2

9.1

4.3

0.29c

Lupus anticoagulantd

36.3

34.3

43.6

0.097c

Anti-cardiolipine

28.5

30.7

19.5

0.23c

Anti-β2-glycoprotein-1f

29.2

30.0

25.9

0.80c

Low complement

47.3

51.3

30.4

0.011c

Direct Coombs testg

51.3

58.1

29.6

0.25c

  1. aACR-82, American College of Rheumatology 1982 criteria; Anti-dsDNA, Antibodies to double-stranded DNA; Anti-Sm, Anti-Smith antibody; Fries, Fries and Holman’s diagnostic principle [7]; SLE, Systemic lupus erythematosus; SLICC-12, 2012 Systemic Lupus International Collaborating Clinics criteria. b P-values based on Mann–Whitney U test. c P-values based on χ2 test. Criteria were tested on any occasion in d182 of 243 patients, e207 of 243 patients, f137 of 243 patients and g113 of 243 patients.